Canada markets open in 3 hours 51 minutes

Atara Biotherapeutics, Inc. (ATRA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.6845-0.0055 (-0.80%)
At close: 04:00PM EDT
0.6800 -0.00 (-0.66%)
After hours: 04:14PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 82.36M
Enterprise Value 88.50M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)8.52
Price/Book (mrq)N/A
Enterprise Value/Revenue 10.32
Enterprise Value/EBITDA -0.33

Trading Information

Stock Price History

Beta (5Y Monthly) 0.72
52-Week Change 3-75.09%
S&P500 52-Week Change 323.57%
52 Week High 33.0150
52 Week Low 30.1990
50-Day Moving Average 30.7116
200-Day Moving Average 31.0593

Share Statistics

Avg Vol (3 month) 31.92M
Avg Vol (10 day) 3906.39k
Shares Outstanding 5119.36M
Implied Shares Outstanding 6119.36M
Float 890.82M
% Held by Insiders 12.77%
% Held by Institutions 160.44%
Shares Short (Apr 15, 2024) 411.45M
Short Ratio (Apr 15, 2024) 49.11
Short % of Float (Apr 15, 2024) 49.80%
Short % of Shares Outstanding (Apr 15, 2024) 49.59%
Shares Short (prior month Mar 15, 2024) 411.03M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,922.44%

Management Effectiveness

Return on Assets (ttm)-62.11%
Return on Equity (ttm)-2,014.86%

Income Statement

Revenue (ttm)8.57M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)1,345.70%
Gross Profit (ttm)N/A
EBITDA -264.45M
Net Income Avi to Common (ttm)-276.13M
Diluted EPS (ttm)-2.6100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)51.73M
Total Cash Per Share (mrq)0.43
Total Debt (mrq)60.49M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.72
Book Value Per Share (mrq)-0.93

Cash Flow Statement

Operating Cash Flow (ttm)-192.98M
Levered Free Cash Flow (ttm)-55.72M